"Leverage the power of the immune system."

Clinical Pipeline


    TRIPLE NEGATIVE BREAST CANCER
  • Pre-Clinical Trial
  • Animal testing study to evaluate the ability of IMMAGE SMART VLP™ Vectors for MAGE-A construct to elicit an immunogenic response in advanced recurrent triple negative breast cancer (TNBC).

    Anti-PD-L1
  • Pre-Clinical Trial
  •  

    Anti-CTL4
  • Pre-Clinical Trial
  •  

Learn more about our current clinical trials.

Subscribe to our mailing list